H2AFV expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 3.6507463718749E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.50710000035303E-08 |
Normal-vs-Stage2 |
2.43469999999801E-05 |
Normal-vs-Stage3 |
1.64013247427874E-12 |
Normal-vs-Stage4 |
3.6422999949437E-08 |
Stage1-vs-Stage2 |
2.675600E-01 |
Stage1-vs-Stage3 |
9.787700E-04 |
Stage1-vs-Stage4 |
1.141010E-01 |
Stage2-vs-Stage3 |
3.486600E-01 |
Stage2-vs-Stage4 |
9.923800E-01 |
Stage3-vs-Stage4 |
2.669600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
5.18629583723396E-11 |
Normal-vs-AfricanAmerican |
1.65556457432103E-12 |
Normal-vs-Asian |
4.024000E-02 |
Caucasian-vs-AfricanAmerican |
3.205800E-04 |
Caucasian-vs-Asian |
7.684000E-01 |
AfricanAmerican-vs-Asian |
8.344200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
9.16866582656439E-12 |
Normal-vs-Female |
5.90610005346548E-10 |
Male-vs-Female |
5.659200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
4.25129999981344E-07 |
Normal-vs-Age(41-60Yrs) |
4.63899996194783E-09 |
Normal-vs-Age(61-80Yrs) |
8.1308293431448E-12 |
Normal-vs-Age(81-100Yrs) |
2.62179999999113E-06 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.041200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.290200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.538000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.962000E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.843600E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.999200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
4.219700E-02 |
Normal-vs-Grade 2 |
6.48410000136934E-08 |
Normal-vs-Grade 3 |
7.20656867514435E-12 |
Normal-vs-Grade 4 |
9.7782004715441E-11 |
Grade 1-vs-Grade 2 |
6.346600E-01 |
Grade 1-vs-Grade 3 |
2.206600E-01 |
Grade 1-vs-Grade 4 |
7.012100E-02 |
Grade 2-vs-Grade 3 |
4.977800E-02 |
Grade 2-vs-Grade 4 |
1.763820E-03 |
Grade 3-vs-Grade 4 |
6.078400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
8.16820000000273E-05 |
Normal-vs-ccB subtype |
5.29798427351125E-13 |
ccA subtype-vs-ccB subtype |
1.93109999999663E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.1428000485102E-09 |
Normal-vs-N1 |
1.740130E-02 |
N0-vs-N1 |
7.157000E-01 |
|
|